Blu-ray Technology-Based Quantitative Assays for Cardiac Markers: From Disc Activation to Multiplex Detection
Samuel Weng1, Xiaochun Li2, Michelle Niu3
1Department of Chemistry, Simon Fraser University , Burnaby, British Columbia V5A 1S6, Canada.
Analytical Chemistry
|June 9, 2016
Summary
A novel Blu-ray disc assay platform enables rapid, low-cost point-of-care diagnosis for acute myocardial infarction (AMI). This technology accurately quantifies key cardiac biomarkers, offering a user-friendly tool for on-site medical analysis.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Point-of-Care Diagnostics
Background:
- Acute myocardial infarction (AMI) is a major global health concern, necessitating rapid and reliable diagnostic methods.
- Current point-of-care (POC) diagnostic tools for AMI often lack the sensitivity or multiplexing capabilities required for comprehensive assessment.
Purpose of the Study:
- To develop a novel, low-cost, and user-friendly Blu-ray disc-based assay for multiplex detection of key cardiac biomarkers for AMI diagnosis.
- To adapt existing Blu-ray technology for quantitative analysis of myoglobin, troponin I, and C-reactive protein.
Main Methods:
- Utilized off-the-shelf Blu-ray discs (BDs) as substrates for immunoassays and DNA aptamer/antibody hybrid assays.
- Employed an unmodified optical Blu-ray drive for digital readout of assay results.
- Quantified three cardiac marker proteins within their physiological ranges of interest.
Main Results:
- Achieved detection limits comparable to conventional enzyme-linked immunosorbent assay (ELISA) kits.
- Validated the Blu-ray assay platform using real-world patient samples.
- Demonstrated a strong linear correlation between Blu-ray assay data and ELISA results.
Conclusions:
- The Blu-ray assay-on-a-BD technique provides a cost-effective and accessible quantitative tool for on-site chemical analysis.
- This platform offers a promising solution for rapid point-of-care medical diagnosis of acute myocardial infarction.
- No hardware or software modifications are required, facilitating widespread adoption.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
717
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
717
Acute Coronary Syndrome III: Diagnostic Studies
389
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
389
Dysrhythmias V: Evaluating Dysrhythmias
462
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
462


